Expert Issues Warning to XRP Holders: $500 Could Change Your Life
XRP currently trades at $1.48, down 3% in the last 24 hours. $500 buys approximately 337.8 XRP tokens. That figure is well below the thresholds many experts have recommended. Financial strategist Sidney M. Brewer has urged holders to store a minimum of 10,000 XRP in cold storage.
Edoardo Farina, CEO of Alpha Lions Academy, set a lower threshold for investors. He called owning fewer than 1,000 XRP “the definition of insanity.” Shield, however, holds a different position. He believes a $500 investment is enough, and many in the community agree.
Support From the Community
Reactions to the post were largely enthusiastic. Shield replied that this cycle could create generational wealth.
Shield also mentioned this target. At $589, that initial $500 investment would be worth almost $199,000.
The Skeptics React
A Major Target Gaining Attention
Dom Kwok, co-founder of EasyA, recently posted that $1,000 is more likely than ever. Kwok has publicly predicted XRP will reach $1,000 by 2030. His post reached hundreds of thousands of views within hours.
At today’s price of $1.48, that target would represent a gain of over 67,000%. The XRP community continues to debate whether the asset’s fundamentals can support such a valuation. However, influential voices are growing louder, and Shield is advising people to accumulate before these targets become reality.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
No-KYC Crypto Exchanges in 2026: Where You Can Still Swap Without ID
VIPEarnings Under Scrutiny Amid High Interest Rates and Platform Recovery
1. U.S. equities gained over the week, while crypto assets declined, reflecting a divergence in risk appetite. From October 3 to 9, the S&P 500 rose 1.15% and the Nasdaq 100 gained 0.24%, while BTC, ETH, and SOL fell 2.31%, 6.84%, and 7.99%, respectively. The U.S. Dollar Index advanced 0.27%, and although the 10-year U.S. Treasury yield declined 3.3 basis points, it remained elevated at 5.244%. High funding costs therefore continued to weigh on risk asset valuations. 2. Weak employment data have not eliminated inflation concerns, while AI and on-chain finance face growing scrutiny over commercial viability. September nonfarm payrolls increased by just 29,000, yet the minutes of the Federal Reserve's September meeting still pointed to the possibility of further rate hikes before year-end. This week's CPI release and major bank earnings will provide important tests of growth and inflation pressures. Revenue recognition and reporting practices in AI, underlying asset rights in RWA, and operating costs for Layer 2 networks are also becoming increasingly important measures of commercial viability. 3. Bitget has completed its phased service restoration, while the Bitget Alliance Program continues to support clients' trading and capital management needs. We completed the planned restoration on October 2 and replenished the Protection Fund to more than $300 million on September 30. According to DefiLlama, assets tracked on the platform rebounded from approximately $5.647 billion on October 1 to $6.223 billion on October 11. This report also outlines VIP level protection, user rewards, and institutional fee incentives to help high-value clients plan their trading activities according to their account type. Assets to watch: BTC, ETH, SOL, SUI, PUMP, gold, JPM, BAC, and ASML. Key areas of focus this week: The October 14 U.S. CPI release; bank net interest income and credit costs; AI cash flow generation; and post-recovery trends in assets held on Bitget, settlement efficiency, and trading conditions. Market data are current through October 9 or the latest local trading day. Official announcements and promotion terms were reviewed through October 12.

How High Can Bitcoin Price Go? Expert Uses Silver’s Rally To Map $400,000 BTC Target

Samsung Biologics reports provisional interim results of PolyPeptide tender offer
